Newsroom

Sorted by: Latest

-

SITE Centers Announces Sale of FlatAcres MarketCenter

BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Announces Sale of FlatAcres MarketCenter...
-

BeOne Medicines annonce ses résultats financiers pour le quatrième trimestre et l’ensemble de l’année 2025, soulignant le succès mondial de BRUKINSA et son leadership fondamental en oncologie

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale spécialisée dans l’oncologie, a annoncé aujourd’hui ses résultats financiers et les dernières actualités de l’entreprise pour le quatrième trimestre et l’ensemble de l’exercice 2025. « Ces solides résultats financiers pour le quatrième trimestre et l’ensemble de l’exercice 2025 soulignent notre évolution continue en tant que leader mondial dans le domaine de l’oncolog...
-

Sturm, Ruger & Company, Inc. to Report Fourth Quarter and Year-End 2025 Financial Results on Monday, March 2

MAYODAN, N.C.--(BUSINESS WIRE)--Sturm, Ruger & Company, Inc. (NYSE: RGR) will announce its financial results for the fourth quarter and year-end 2025 and file its Annual Report on Form 10-K on Monday, March 2, 2026, after the close of the stock market. That evening, Sturm, Ruger will host a webcast at 4:30 p.m. ET to discuss the fourth quarter and year-end 2025 operating results. Interested parties can listen to the webcast via this link or by visiting Ruger.com/corporate. Those who wish to...
-

BeOne Medicines anuncia los resultados financieros del cuarto trimestre y del año completo 2025, destacando el éxito mundial de BRUKINSA y su liderazgo fundamental en oncología

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), una empresa oncológica mundial, anunció el día de hoy los resultados financieros y las novedades corporativas del cuarto trimestre y del ejercicio completo de 2025. "Estos sólidos resultados financieros del cuarto trimestre y de todo el año 2025 subrayan nuestra continua evolución como líder mundial en oncología, con ventajas competitivas duraderas en el desarrollo clínico y la fabricación, y una...
-

Syncora Guarantee Inc. Announces the Availability of Certain Financial Information

NEW YORK--(BUSINESS WIRE)--Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Annual Statement containing the unaudited Statutory Basis Financial Statements as of December 31, 2025 filed with the NAIC. About Syncora Guarantee Inc. Syncora Guarantee Inc. is a New York-domiciled insurance company that is...
-

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2025. Financial Results Revenue Consolidated revenues for fiscal 2025 were $31.6 million compared to $32.0 million for fiscal 2024. The revenues for fiscal 2025 consisted of $31.4 million in processing and storage fee revenue, $54,000 in product revenue...
-

Samenvatting: ALTASCIENCES KONDIGT AAN DAT CHRIS PERKIN IS BENOEMD TOT LID VAN DE RAAD VAN BESTUUR; MARIE-HÉLÈNE RAIGNEAU IS BENOEMD TOT CHIEF EXECUTIVE OFFICER

LAVAL, Québec--(BUSINESS WIRE)--Altasciences heeft vandaag bekendgemaakt dat Chris Perkin is benoemd tot lid van de raad van bestuur van het bedrijf, met ingang van dinsdag 24 februari 2026. Nadat zij in de afgelopen 12 maanden haar leiderschap heeft overgedragen, is Marie-Hélène Raigneau, sinds april 2025 president van het bedrijf, benoemd tot Chief Executive Officer, eveneens met ingang van dinsdag 24 februari 2026. “Ik heb meer dan twintig jaar met Marie-Hélène samengewerkt en heb er alle ve...
-

IQVIA Releases its 2025 Sustainability Report

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today published its 2025 Sustainability Report. The report highlights IQVIA’s progress across its People, Public and Planet pillars, consistent with the company’s mission to accelerate innovation for a healthier world. IQVIA’s 2025 Sustainability Report can be downl...
-

Securities Fraud Investigation Into Franklin BSP Realty Trust, Inc. (FBRT) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Franklin BSP Realty Trust, Inc. (“FBRT” or the “Company”) (NYSE: FBRT) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FRANKLIN BSP REALTY TRUST, INC. (FBRT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On February 11, 2026, FBRT released its fourth...
-

KBRA Releases Research – CMBS Loan Performance Trends: February 2026

NEW YORK--(BUSINESS WIRE)--The 30+ day delinquency rate among KBRA-rated U.S. private label commercial mortgage-backed securities (CMBS) decreased to 7.5% in February from 8.1% in January, while the distress rate (reflecting delinquent plus current-but-specially-serviced loans) decreased to 10.3% from 10.7%. The office delinquency rate decreased 110 basis points (bps) this month to 12.8%. As reported last month, One New York Plaza ($810 million in ONYP 2020-1NYP) was modified and extended, whic...